$DOUG

Douglas Elliman Inc.

0
0
1

No SEC Form 4 filings for $DOUG in the last 30 days.

Med

Elliman’s weak first-quarter performance casts doubt on turnaround

Douglas Elliman, after briefly returning to profitability in Q4 2025, reported a $16 million loss in Q1 2026, driven by reduced home sales, a decline in development marketing revenue, and increased litigation costs. This performance casts doubt on the company's turnaround efforts, despite a previously touted "new era" and a debt-free balance sheet. The firm faces challenges including intense competition in new development markets and significant payments related to an antitrust settlement.

Byron Trott and Michael Dell’s firm taps Elliman to lead sales of luxury Boca Raton condos

BDT & MSD Partners, the firm backed by Byron Trott and Michael Dell, has appointed Douglas Elliman to manage sales and marketing for the Residences at Boca Raton, a new luxury condo development. The 75-unit building will offer condos priced from $5 million to $15 million and is being built on the Boca Raton Club site. This project follows a land use approval in March and marks a significant investment by BDT & MSD in the luxury hospitality sector since its 2023 merger.

Douglas Elliman (NYSE: DOUG) awards 175,000-share restricted stock grant to GC

Douglas Elliman Inc. (NYSE: DOUG) has granted its SVP, General Counsel, and Secretary, Brodie Bradley Harris, a restricted stock award of 175,000 shares of common stock. This grant, made under the company’s 2021 Management Incentive Plan, will vest in three equal annual installments starting December 15, 2026, contingent on continued employment. Following this transaction, Harris directly holds 425,000 shares of Douglas Elliman common stock.